Lupus

Systemic lupus erythematosus (SLE), also called lupus, is an autoimmune disorder characterized by the immune system attacking the body's own tissues and organs, leading to inflammation and damage. The severity of the disease varies, from mild cases only involving the skin to severe cases affecting multiple organs, including the brain. Lupus sufferers experience flares, or intervals of active disease, and remissions in disease. The disease most predominantly occurs in women of childbearing age, but also affects children, adolescents, and men. While the cause of lupus is still unknown, various genetic, environmental, and infectious causes have been associated with its development. Current treatments for lupus vary depending on the extent of the disease, and may change over time. Some medications used to ease symptoms include nonsteroidal anti-inflammatory drugs, antimalarial drugs, corticosteroids, and immunosuppressive medications, though many of these drugs carry their own risks.
What is Lupus?

Lupus, also called systemic lupus erythematosus or SLE, is a disease that affects your immune system. Normally, your immune system fights infections caused by germs.

Read More

Overview

Feature Articles

Latest Lupus News and Research

Evidence of SARS-CoV-2 placental infection in mild COVID-19

Evidence of SARS-CoV-2 placental infection in mild COVID-19

One in three young adults at a higher risk of severe COVID-19 due to smoking, vaping

One in three young adults at a higher risk of severe COVID-19 due to smoking, vaping

Study shows smoking is associated with a higher likelihood of COVID-19 progression

Study shows smoking is associated with a higher likelihood of COVID-19 progression

New method helps pinpoint new potential therapeutic targets for lupus

New method helps pinpoint new potential therapeutic targets for lupus

Research sheds light on mysterious COVID-19 related hyperinflammatory shock in children

Research sheds light on mysterious COVID-19 related hyperinflammatory shock in children

ACE inhibition in kidney could influence pathogenesis of SARS-CoV-2

ACE inhibition in kidney could influence pathogenesis of SARS-CoV-2

Colombian corona hounds: SAR-CoV-2 detection by dogs

Colombian corona hounds: SAR-CoV-2 detection by dogs

Researchers find prothrombotic antibodies in patients with COVID-19

Researchers find prothrombotic antibodies in patients with COVID-19

Study initiates hydroxychloroquine clinical trial to prevent COVID-19 in healthy people

Study initiates hydroxychloroquine clinical trial to prevent COVID-19 in healthy people

Turning autoimmunity drugs into anti-cancer treatments

Turning autoimmunity drugs into anti-cancer treatments

Hydroxychloroquine suppresses 'trained immunity'

Hydroxychloroquine suppresses 'trained immunity'

Immuno-oncology may accelerate the development of treatments for COVID-19

Immuno-oncology may accelerate the development of treatments for COVID-19

Fecal transplants could be used as treatment for non-alcoholic fatty liver disease

Fecal transplants could be used as treatment for non-alcoholic fatty liver disease

Georgia State researcher receives $1.95 million NIH grant to study cause of autoimmunity

Georgia State researcher receives $1.95 million NIH grant to study cause of autoimmunity

Health care providers urged to stop hydroxycholoroquine use for COVID-19

Health care providers urged to stop hydroxycholoroquine use for COVID-19

Lancet issues correction on paper than prompted WHO to suspend Hydroxychloroquine trial

Lancet issues correction on paper than prompted WHO to suspend Hydroxychloroquine trial

Researchers develop new method to measure hydroxychloroquine levels in SLE patients

Researchers develop new method to measure hydroxychloroquine levels in SLE patients

Researchers use optical mapping system to observe the effect of hydroxychloroquine

Researchers use optical mapping system to observe the effect of hydroxychloroquine

Study examines changes in prescription patterns during COVID-19 pandemic

Study examines changes in prescription patterns during COVID-19 pandemic

Treatment with chloroquine or hydroxychloroquine offers no benefit for COVID-19 patients

Treatment with chloroquine or hydroxychloroquine offers no benefit for COVID-19 patients